Rituximab for Pediatric Central Nervous System Inflammatory Disorders in Alberta, Canada
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2024
DOI: 10.1017/cjn.2023.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2024. Verfasst von Ihor Pecuh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Alberta Health Services, Edmonton, Canada. Hauptthemen laut MEDLINE: Central Nervous System Diseases, Autoimmune Diseases of the Nervous System, Encephalitis, Hashimoto Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Early and effective treatment of central nervous system (CNS) inflammatory disorders is vital to reduce neurologic morbidity and improve long-term outcomes in affected children. Rituximab is a B-cell-depleting monoclonal antibody whose off-label use for these disorders is funded in the province of Alberta, Canada, by the Short-Term Exceptional Drug Therapy (STEDT) program. This study describes the use of rituximab for pediatric CNS inflammatory disorders in Alberta.
Methods
Rituximab applications for CNS inflammatory indications in patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Alberta Health Services, Edmonton, Canada.
- Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada.
- Division of Neurology, Department of Pediatrics, University of Alberta, Edmonton, Canada.
- Women and Children's Health Research Institute, Edmonton, Canada.
ORCID-Profile: Jennifer A McCombe, Colin Wilbur
Zitieren
APA
Pecuh, I., Slobodan, J., McCombe, J. A., Morneau-Jacob, F. D., Smyth, P., & Wilbur, C. (2024). Rituximab for Pediatric Central Nervous System Inflammatory Disorders in Alberta, Canada. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2023.16
Vancouver
Pecuh I, Slobodan J, McCombe JA, Morneau-Jacob FD, Smyth P, Wilbur C. Rituximab for Pediatric Central Nervous System Inflammatory Disorders in Alberta, Canada. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2024. doi:10.1017/cjn.2023.16
BibTeX
@article{Pecuh2024,
author = {Pecuh, Ihor and Slobodan, Jeremy and McCombe, Jennifer A and Morneau-Jacob, Francois-Dominique and Smyth, Penelope and Wilbur, Colin},
title = {Rituximab for Pediatric Central Nervous System Inflammatory Disorders in Alberta, Canada},
journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
year = {2024},
doi = {10.1017/cjn.2023.16}
}
EUVIMED